Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 20532957)

1.

A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.

Kern JK, Geier DA, Adams JB, Geier MR.

Biometals. 2010 Dec;23(6):1043-51. doi: 10.1007/s10534-010-9349-6. Epub 2010 Jun 9.

PMID:
20532957
2.

A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders.

Geier DA, Kern JK, Geier MR.

J Toxicol Environ Health A. 2009;72(24):1585-91. doi: 10.1080/15287390903232475.

PMID:
20077233
3.

Biomarkers of environmental toxicity and susceptibility in autism.

Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR.

J Neurol Sci. 2009 May 15;280(1-2):101-8. doi: 10.1016/j.jns.2008.08.021. Epub 2008 Sep 25.

PMID:
18817931
4.

A prospective study of mercury toxicity biomarkers in autistic spectrum disorders.

Geier DA, Geier MR.

J Toxicol Environ Health A. 2007 Oct;70(20):1723-30.

PMID:
17885929
5.

Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins.

Kern JK, Geier DA, Adams JB, Mehta JA, Grannemann BD, Geier MR.

Pediatr Int. 2011 Apr;53(2):147-53. doi: 10.1111/j.1442-200X.2010.03196.x.

PMID:
20626635
6.
7.

Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.

Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R.

Toxicol Appl Pharmacol. 2006 Jul 15;214(2):99-108. Epub 2006 Jun 16.

PMID:
16782144
8.

Porphyrinuria in Korean children with autism: correlation with oxidative stress.

Youn SI, Jin SH, Kim SH, Lim S.

J Toxicol Environ Health A. 2010;73(10):701-10. doi: 10.1080/15287391003614000.

PMID:
20391113
9.

Disordered porphyrin metabolism: a potential biological marker for autism risk assessment.

Heyer NJ, Echeverria D, Woods JS.

Autism Res. 2012 Apr;5(2):84-92. doi: 10.1002/aur.236. Epub 2012 Feb 1.

10.
11.

Porphyrinuria in childhood autistic disorder is not associated with urinary creatinine deficiency.

Nataf R, Skorupka C, Lam A, Springbett A, Lathe R.

Pediatr Int. 2008 Aug;50(4):528-32. doi: 10.1111/j.1442-200X.2008.02621.x.

PMID:
19143977
12.

Modeling clinical outcome of children with autistic spectrum disorders.

Coplan J, Jawad AF.

Pediatrics. 2005 Jul;116(1):117-22.

PMID:
15995041
13.
14.

A review of candidate urinary biomarkers for autism spectrum disorder.

Wang L, Angley MT, Gerber JP, Sorich MJ.

Biomarkers. 2011 Nov;16(7):537-52. doi: 10.3109/1354750X.2011.598564. Review.

PMID:
22022826
15.

Follow up of children with autism spectrum disorders: stability and change in diagnosis.

Malhi P, Singhi P.

Indian J Pediatr. 2011 Aug;78(8):941-5. doi: 10.1007/s12098-011-0370-8. Epub 2011 Feb 12.

PMID:
21318394
16.

Etiologic yield of autistic spectrum disorders: a prospective study.

Battaglia A, Carey JC.

Am J Med Genet C Semin Med Genet. 2006 Feb 15;142C(1):3-7.

PMID:
16419094
17.
18.

Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?

Wang L, Angley MT, Gerber JP, Young RL, Abarno DV, McKinnon RA, Sorich MJ.

Biomarkers. 2009 Dec;14(8):596-603. doi: 10.3109/13547500903183962.

PMID:
19697973
19.
20.

Autism spectrum disorders at 20 and 42 months of age: stability of clinical and ADI-R diagnosis.

Cox A, Klein K, Charman T, Baird G, Baron-Cohen S, Swettenham J, Drew A, Wheelwright S.

J Child Psychol Psychiatry. 1999 Jul;40(5):719-32.

PMID:
10433406
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk